Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 4.3B 635M 558M 519M 476M 894M 61.14B 908M 6.16B 2.41B 30.06B 2.38B 2.33B 104B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.13B 610M 536M 498M 457M 859M 58.74B 872M 5.92B 2.31B 28.88B 2.29B 2.24B 99.84B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day-4.03%
1 week-5.01%
Current month-3.65%
1 month-4.65%
3 months-20.54%
6 months-22.05%
Current year-6.93%
1 week 7.15
Extreme 7.15
7.94
1 month 7.08
Extreme 7.08
8.78
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.98
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
15.19
Manager TitleAgeSince
Chief Executive Officer 42 11/12/2017
Director of Finance/CFO 34 01/08/2019
Chief Operating Officer 45 25/08/2022
Director TitleAgeSince
Chairman 42 01/08/2019
Chairman 48 21/03/2019
Director/Board Member 46 21/03/2019
Date Insider Type Main position Quantity % Market Cap.
14/9/21 Sell

Executive/Senior Manager

10,000 0.0025%
10/9/21 Sell

Executive/Senior Manager

77,000 0.0189%
9/6/21 Sell

Executive/Senior Manager

60,000 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
-4.03%-5.01%-15.45%+10.79% 635M
+0.86%+1.43%+47.17%+161.40% 1,067B
+1.59%+4.09%+56.51%+52.79% 635B
+0.95%+1.91%+36.30%+83.13% 458B
+1.60%+6.25%+37.00%+30.00% 347B
-0.60%+1.52%+36.67%+39.80% 295B
-0.14%+0.60%+17.29%+18.19% 262B
+0.09%-2.82%-29.09%-41.29% 216B
+1.22%+2.66%+22.66%+59.81% 203B
-1.18%-3.70%+11.28%+67.43% 161B
Average +0.04%+0.85%+22.03%+48.21% 364.41B
Weighted average by Cap. +0.76%+1.95%+35.98%+78.14%

Financials

2024 2025
Net sales 984M 145M 128M 119M 109M 205M 13.99B 208M 1.41B 550M 6.88B 545M 534M 23.78B 1.21B 178M 156M 145M 133M 251M 17.14B 255M 1.73B 675M 8.43B 668M 654M 29.14B
Net income 13.65M 2.02M 1.77M 1.65M 1.51M 2.84M 194M 2.88M 19.56M 7.64M 95.46M 7.57M 7.41M 330M 92.73M 13.7M 12.03M 11.19M 10.27M 19.29M 1.32B 19.59M 133M 51.9M 648M 51.41M 50.31M 2.24B
Net Debt 189M 27.93M 24.53M 22.81M 20.93M 39.33M 2.69B 39.93M 271M 106M 1.32B 105M 103M 4.57B -169M -24.93M -21.9M -20.36M -18.69M -35.11M -2.4B -35.65M -242M -94.48M -1.18B -93.59M -91.58M -4.08B
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
24/07/26 CNY 7.390 -4.03% 14,678,436
23/07/26 CNY 7.700 +1.85% 16,190,736
22/07/26 CNY 7.560 +0.40% 19,804,200
21/07/26 CNY 7.530 -1.57% 22,240,064
20/07/26 CNY 7.650 -1.67% 21,299,950

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock